Unverified50% confidenceCautionExact time
The disease labels used in the study are proxy labels, not clinical gold-standard grading, and independent reference caliber measurements are lacking, so the 96.7% accuracy only demonstrates that the pipeline is feasible in exploratory settings, not clinically usable screening performance.
1
Sources
50%
Confidence
Medium-term (~90 days)
Relevance
11/11/2026
First Seen
Valid until: 2/9/2027
Sources
Related Entities
Related Claims
Cite This Claim
Stable URI
https://kongchang.com/claim/1158143API
curl https://kongchang.com/api/v1/knowledge/claims/1158143MCP
get_claim(id=1158143)